Trials / Terminated
TerminatedNCT03510988
Dedicated Breast PET/MRI in Evaluation of Extent of Disease in Women With Newly Diagnosed Breast Cancer
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Weill Medical College of Cornell University · Academic / Other
- Sex
- Female
- Age
- 25 Years
- Healthy volunteers
- Not accepted
Summary
This is a single institution study enrolling women over age 25 with newly diagnosed breast cancer and for whom a breast MR has been ordered as standard of care. Subjects will undergo a hybrid dedicated Breast PET/MRI in lieu of a breast MRI alone, for evaluation of extent of disease prior to surgical and oncologic management. The study will investigate any incremental added benefit to breast MRI specificity by the addition of concurrent hybrid breast PET.
Detailed description
The study hypothesis is that the combination of Breast PET/MRI, will improve specificity and decrease the number of false positive breast biopsies recommended based on breast MRI findings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Hybrid breast FDG PET/MRI | Hybrid breast FDG PET/MRI |
Timeline
- Start date
- 2018-03-15
- Primary completion
- 2020-03-04
- Completion
- 2022-03-04
- First posted
- 2018-04-27
- Last updated
- 2023-02-22
- Results posted
- 2023-02-22
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03510988. Inclusion in this directory is not an endorsement.